Reconstructing and Deconstructing Agonist-Induced Activation of Integrin αIIbβ3
Jaewon Han(University of California San Diego), Mark Ginsberg(University of California San Diego), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Sanford J. Shattil(University of California San Diego), Esther M. Lafuente(Universidad Complutense de Madrid), Wilma Puzon-McLaughlin(Scripps Research Institute), Alessandra Soriani(Institute of Molecular Medicine), Naohide Watanabe(Keio University), David Calderwood(Yale Cancer Center), Boris I. Ratnikov(University of California San Diego), Chinten James Lim(BC Children's Hospital)
Cited by 437
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
|Science|1993|914
The complex role of tumor-infiltrating macrophages
|Nature Immunology|2022|859